Continued Metformin Beneficial for Diabetes With Cirrhosis

This article originally appeared here.
Share this content:
Continued Metformin Beneficial for Diabetes With Cirrhosis
Continued Metformin Beneficial for Diabetes With Cirrhosis

TUESDAY, Dec. 9, 2014 (HealthDay News) -- Continuation of metformin therapy may improve survival in diabetes patients who are diagnosed with cirrhosis, according to research published in the December issue of Hepatology.

Xiaodan Zhang, of the Mayo Clinic College of Medicine in Rochester, Minn., and colleagues conducted a retrospective study of 250 patients with diabetes who were receiving metformin at the time of diagnosis with cirrhosis. The effect of continued therapy with metformin on survival was investigated.

The researchers found that 172 patients continued metformin therapy and 78 patients discontinued the medication. Median survival was longer in patients who continued metformin than in those who did not (11.8 versus 5.6 years overall; P < 0.0001). Similar patterns were observed for patients with Child-Pugh A scores or Child-Pugh B/C scores. Following multivariable adjustment, continued therapy with metformin remained an independent predictor of improved survival (hazard ratio, 0.43; P = 0.005). During follow-up, none of the patients experienced metformin-related lactic acidosis.

"Continuation of metformin after cirrhosis diagnosis reduced the risk of death by 57 percent," the authors write. "Metformin should therefore be continued in diabetic patients with cirrhosis if there is no specific contraindication."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »